Anavex Life Sciences
AVXL
#8657
Rank
โ‚น22.19 B
Marketcap
โ‚น239.49
Share price
-2.75%
Change (1 day)
-79.34%
Change (1 year)

EPS for Anavex Life Sciences (AVXL)

EPS in 2025 (TTM): -โ‚น39.98

According to Anavex Life Sciences 's latest financial reports the company's current EPS (TTM) is -โ‚น44.42. a decrease over its 2024 EPS that were of -โ‚น50.22.

EPS history for Anavex Life Sciences from 2004 to 2025

Annual EPS

Year EPS Change
2025-โ‚น52.153.85%
2024-โ‚น50.22-13.33%
2023-โ‚น57.94-3.23%
2022-โ‚น59.8714.81%
2021-โ‚น52.1520%
2020-โ‚น43.46-16.67%
2019-โ‚น52.1538.46%
2018-โ‚น37.6618.18%
2017-โ‚น31.87-21.43%
2016-โ‚น40.56-35.38%
2015-โ‚น62.77-36.27%
2014-โ‚น98.50112.5%
2013-โ‚น46.35-58.62%
2012-โ‚น112.02-0%
2011-โ‚น112.02-29.27%
2010-โ‚น158.3751.85%
2009-โ‚น104.30-0%
2008-โ‚น104.30237.5%
2007-โ‚น30.90
2006N/A-100%
2005-โ‚น3.86499.97%
2004-โ‚น0.64

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Ligand Pharmaceuticals
LGND
โ‚น757.11-1,804.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
โ‚น43.46-197.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-โ‚น729.10 1,541.30%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-โ‚น167.07 276.09%๐Ÿ‡บ๐Ÿ‡ธ USA